• 1
    Katz AM, Katz PB. Diseases of the heart in the works of Hippocrates. Br Heart J 1962;24:257264.
  • 2
    Blackburn GL, Gibbons GW, Bothe A., et al. Nutritional support in cardiac cachexia. J Thorac Cardiovasc Surg 1977;73:489496.
  • 3
    Roubenoff R., Kehayias JJ. Meaning and measurement of lean body mass. Nutr Rev 1991;49:163175.
  • 4
    O'Meara MP, Birkenfeld LW, Gotch FA, Edelman IS. Equilibration of radiosodium (N24), radiopotassium (K42), and deuterium oxide (D2O) in hydropic human subjects. J Clin Invest 1957;30:784792.
  • 5
    Thomas RD, Silverton NP, Burkinshaw L., Morgan DB. Potassium depletion and tissue loss in chronic heart-disease. Lancet 1979;1:911.
  • 6
    Abel RM, Fischer JE, Buckley MJ, et al. Malnutrition in cardiac surgical patients. Arch Surg 1976;111:4550.
  • 7
    Shindo K., Minami C., Yamazaki K., et al. Factors affecting postoperative ventilatory support in patients with cardiac cachexia. J Cardiothorac Anesth 1989;3:455460.
  • 8
    Hill GL. Body composition research: Implications for the practice of clinical nutrition. J Parenter Enteral Nutr 1992;16:197218.
  • 9
    Freeman LM, Roubenoff R. Nutrition implications of cardiac cachexia. Nutr Rev 1994;52:340347.
  • 10
    Mahoney SM, Tisdale MJ. Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor. Br J Cancer 1988;58:345349.
  • 11
    Dinarello CA, Endres S., Meydani SN, et al. Interleukin-1. anorexia, and dietary fatty acids. Ann N Y Acad Sci 1990; 587: 332338.
  • 12
    Roubenoff R., Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:23792386.
  • 13
    Llovera M., Lopez-Soriano FJ, Argues JM. Effects of tumor necrosis factor on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst 1993;85:13341339.
  • 14
    McMurray J., Abdullah I., Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in “cachectic” patients with severe chronic heart failure. Br Heart J 1991;66:356358.
  • 15
    Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236241.
  • 16
    Pritchett G., Cohen HJ, Rao KMK et al. Tumor necrosis factor, natural killer activity and other measures of immune function and inflammation in elderly men with heart failure. Gerontology 1995;41:4556.
  • 17
    Freeman LM, Rush JE, Brown DJ, Roubenoff R. Elevated concentrations of tumor necrosis factor in dogs with congestive heart failure. J Vet Intern Med 1994;8:146.
  • 18
    Endres S., Ghorbani R., Kelley VE, et al. Effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265271.
  • 19
    Meydani SN, Endres S., Woods MM, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 1991;121:547555.
  • 20
    Tisdale MJ, Dhesi JK. Inhibition of weight loss by n-3 fatty acids in an experimental cachexia model. Cancer Res 1990;50:50225026.
  • 21
    Robinson DR, Urakaze M., Huang R., et al. Dietary marine lipids suppress the continuous expression of interleukin-1β gene transcription. 2nd Conference of the International Society for the Study of Fatty Acids and Lipids, Bethesda, MD, 1995.
  • 22
    Keene BW, Rush JE. Therapy of heart failure. In: EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine. 4th ed. Philadelphia , PA : WB Saunders: 1995:867892.
  • 23
    National Research Council. Nutrient Requirements of Dogs. Washington , DC : National Academy Press; 1985:25.
  • 24
    Kendall C., Coplen TB. Multisample conversion of water to hydrogen by zinc for stable isotope determination. Anal Chem 1985;57:14371440.
  • 25
    Coplen TB, Wildman JD, Chen J. Improvements in the gaseous hydrogen-water equilibration technique for hydrogen isotope ratio analysis. Anal Chem 1991;63:910912.
  • 26
    Dolnikowski GG. A new sample preparation method for isotope ratio mass spectrometry of 2H-enriched samples generated by the doubly labeled water method. Obes Res 1995;3(Suppl 1):7374.
  • 27
    Wilkinson MJA, McEwan NA. Use of ultrasound in the measurement of subcutaneous fat and prediction of total body fat in dogs. J Nutr 1991;121:S47S50.
  • 28
    Frey RS, Hathaway MR, Dayton WR. Comparison of the effectiveness of various procedures for reducing or eliminating insulin-like growth factor-binding protein interference with insulin-like growth factor-1 radioimmunoassays on porcine sera. J Endocrinol 1994;140:229237.
  • 29
    Caruso U., Fowler M., Erceg M., Romano C. Determination of very-long chain fatty acids in plasma by a simplified gas chromato-graphic-mass spectrometric procedure. J Chromatogr 1991;562:147152.
  • 30
    Sukhija PS. Rapid method for determination of total fatty acid content and composition of feedstuffs and feces. J Agric Food Chem 1988;36:12021205.
  • 31
    Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164. clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99105.
  • 32
    Orencole SF, Dinarello CA. Characterization of a subclone (D10S) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens. Cytokine 1989; 1: 1421.
  • 33
    McCosh EJ, Meyer DL, Dupont J. Radioimmunoassay of prostaglandins E1, E2. and F2α in unextracted plasma, serum, and myocardium. Prostaglandins 1976; 12: 471485.
  • 34
    Hayek MG, Meydani SN, Meydani M., Blumberg JB. Age differences in eicosanoid production of mouse splenocytes: Effects on mitogen-induced T-cell proliferation. J Gerontol 1994;49:B197B207.
  • 35
    Schulz R., Panas PL, Catena R., et al. Role of nitric oxide in cardiac depression induced by interleukin-1B and tumour necrosis factor-α. Br J Pharmacol 1995;114:2734.
  • 36
    Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387389.
  • 37
    LaPointe MC, Sitkins JR. Mechanisms of interleukin-1B regulation of nitric oxide synthase in cardiac myocytes. Hypertension 1996;27:709714.
  • 38
    Flores EA, Bistrian BR, Pomposelli JJ, et al. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat: A synergistic effect with interleukin-1. J Clin Invest 1989;83:16141622.
  • 39
    Low-Friedrich I., Weinsensee D., Mitrou P., Schoeppe W. Cytokines induce stress protein formation in cultured cardiac myocytes. Basic Res Cardiol 1992;87:1218.
  • 40
    Monnet E., Orton CE, Salman M., Boon J. Idiopathic dilated cardiomyopathy in dogs: Survival and prognostic indicators. J Vet Int Med 1995;9:1217.
  • 41
    Clemmons DR, Underwood LE, Dickerson RN, et al. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985;41:191198.
  • 42
    Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983;71:175182.
  • 43
    Zhu ZR, Agren J., Peitinen P., et al. Fatty acid composition in breast adipose tissue in breast cancer patients and in patients with benign breast disease. 2nd Conference of the International Society for the Study of Fatty Acids and Lipids, Bethesda, MD, 1995.
  • 44
    Dwyer JT. Dietary assessment. In: ShilsME, OlsonJA, ShikeM., eds. Modern Nutrition in Health and Disease, 8th ed. Philadelphia , PA : Lea and Febiger: 1994:842860.
  • 45
    Schindler R., Dinarello CA, Koch K. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin-1 by human peripheral blood mononuclear cells. Cytokine 1995;7:526533.
  • 46
    Testa M., Yeh M., Lee P., et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996;28:964971.
  • 47
    Torre-Amione G., Kapadia S., Benedict C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996;27:12011206.
  • 48
    Milani RV, Endres S., Mehra MR, et al. Modulation of tumor necrosis factor a in advanced heart failure with cachexia is associated with anabolic effects. J Am Coll Cardiol 1996;27:70A71A (abstract).
  • 49
    Chang HR, Arsenijevic D., Pechere JC, et al. Dietary supplementation with fish oil enhances in vivo synthesis of tumor necrosis factor. Immunol Lett 1992;34:1318.